Terms: = Leukemia AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Prognosis
4599 results:
1.
Wang JN; Ye B; Cheng F; Yang L; Hu Y; Zheng G; Cai Z; Yu J; Wu W
Hematology; 2024 Dec; 29(1):2423324. PubMed ID: 39499083
[TBL] [Abstract] [Full Text] [Related]
2. Lymphocyte subsets in pediatric acute lymphoblastic leukemia and their prognostic value.
Peng L; Dai Q; Wang Y; Yang H; Shi R; Zhang G; Jiang Y; Ye L
Medicine (Baltimore); 2024 Nov; 103(44):e40342. PubMed ID: 39496014
[TBL] [Abstract] [Full Text] [Related]
3. Impact of Simultaneous Presence of Multiple PML-RARA Isoforms on Phenotype in Patients with Acute Promyelocytic Leukaemia.
Goktas E; Zamani AG; Yildirim MS; Demircioglu S; Tekinalp A; Ceneli O
J Coll Physicians Surg Pak; 2024 Nov; 34(11):1552-1556. PubMed ID: 39491447
[TBL] [Abstract] [Full Text] [Related]
4. [Clinical Characteristics and Survival Analysis of Single Center Adult Chronic Myeloid leukemia in Chronic Phase].
Jiao XX; Zhang YY; Pan J; Song LN; Lin CQ; Shi HZ; Zhu B; Wang SL; Pan SY; Ding ZY; Zhao WL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1381-1387. PubMed ID: 39479820
[TBL] [Abstract] [Full Text] [Related]
5. [Clinical Characteristics and prognosis of Children with Hypodiploid B-cell Precursor Acute Lymphoblastic leukemia].
Chen CX; Weng KZ; Wen H; Zhuang SQ; Wu XG; Zheng YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Oct; 32(5):1356-1364. PubMed ID: 39479816
[TBL] [Abstract] [Full Text] [Related]
6. [Prognostic factors in children with acute T-lymphoblastic leukemia: a single-center clinical study of the CCCG-ALL-2015 protocol].
Fu WF; Fang YJ
Zhongguo Dang Dai Er Ke Za Zhi; 2024 Oct; 26(10):1078-1085. PubMed ID: 39467678
[TBL] [Abstract] [Full Text] [Related]
7. Construction of a five-gene-based prognostic model for relapsed/refractory acute lymphoblastic leukemia.
Zhou B; Min B; Liu W; Li Y; Zhu F; Huang J; Fang J; Chen Q; Wu D
Hematology; 2024 Dec; 29(1):2412952. PubMed ID: 39453390
[TBL] [Abstract] [Full Text] [Related]
8. Epigenome-wide analysis across the development span of pediatric acute lymphoblastic leukemia: backtracking to birth.
Ghantous A; Nusslé SG; Nassar FJ; Spitz N; Novoloaca A; Krali O; Nickels E; Cahais V; Cuenin C; Roy R; Li S; Caron M; Lam D; Fransquet PD; Casement J; Strathdee G; Pearce MS; Hansen HM; Lee HH; Lee YS; de Smith AJ; Sinnett D; Håberg SE; McKay JA; Nordlund J; Magnus P; Dwyer T; Saffery R; Wiemels JL; Munthe-Kaas MC; Herceg Z
Mol Cancer; 2024 Oct; 23(1):238. PubMed ID: 39443995
[TBL] [Abstract] [Full Text] [Related]
9. New ABL1 Kinase Domain Mutations in bcr::ABL1-Positive Acute Lymphoblastic leukemia.
Li Z; Peng D; Deng J; Xiong L; Yin P; Hu J; Qian C; Yao L; Yin H; Hong M; Wu Q
Cancer Med; 2024 Oct; 13(20):e70317. PubMed ID: 39440695
[TBL] [Abstract] [Full Text] [Related]
10. Recent Developments and Evolving Therapeutic Strategies in KMT2A-Rearranged Acute leukemia.
Yin L; Wan L; Zhang Y; Hua S; Shao X
Cancer Med; 2024 Oct; 13(20):e70326. PubMed ID: 39428967
[TBL] [Abstract] [Full Text] [Related]
11. The significance of MRD-based strategy by dynamic assessment to guide treatment decisions in B-ALL - the enlightenment provided by demonstrating survival differences in the retrospective study.
Chen Y; Liu R; Li J
Hematology; 2024 Dec; 29(1):2415589. PubMed ID: 39417653
[TBL] [Abstract] [Full Text] [Related]
12. [Ruxolitinib combined with venetoclax and azacitidine in the treatment of refractory T-ALL patients with JAK1, JAK3, and STAT5B gene mutations: a case report and literature review].
Xu PP; Zhou T; Xu YY; Peng MX; Du Y; Xie T; Yang YG; Ouyang J; Chen B
Zhonghua Xue Ye Xue Za Zhi; 2024 Sep; 45(9):872-875. PubMed ID: 39414615
[TBL] [Abstract] [Full Text] [Related]
13. [Clinical analysis of 7 cases of acute B cell lymphoblastic leukemia with t (17;19) (q21-22;p13)/TCF3-HLF fusion].
Pu Y; Liu Y; Zhou XY; Song BQ; Zhang J; Yan WH; Wang Q; Cen JN; Shen HJ; Wang QR; Chen SN; Pan JL; Qiu HY
Zhonghua Xue Ye Xue Za Zhi; 2024 Sep; 45(9):867-871. PubMed ID: 39414614
[TBL] [Abstract] [Full Text] [Related]
14. Enhancer looping protein LDB1 modulates MYB expression in T-ALL cell lines in vitro by cooperating with master transcription factors.
Li Y; Zhang Z; Yu J; Yin H; Chu X; Cao H; Tao Y; Zhang Y; Li Z; Wu S; Hu Y; Zhu F; Gao J; Wang X; Zhou B; Jiao W; Wu Y; Yang Y; Chen Y; Zhuo R; Yang Y; Zhang F; Shi L; Hu Y; Pan J; Hu S
J Exp Clin Cancer Res; 2024 Oct; 43(1):283. PubMed ID: 39385230
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic Relevance of Immunophenotyping in Adult Patients with Acute leukemia in Turkey: A Single-Center Experience.
Demirelce O; Orhan B; Sonmez D; Topac FH; Turk RI; Altindal S; Inal BB
Clin Lab; 2024 Oct; 70(10):. PubMed ID: 39382931
[TBL] [Abstract] [Full Text] [Related]
16. Investigation of Clinical Value of NKT-like Cells in Tumor Diseases.
Chen Y; Yang X; Gu C; Zhang Z; Yang X
Clin Lab; 2024 Oct; 70(10):. PubMed ID: 39382907
[TBL] [Abstract] [Full Text] [Related]
17. [Chronic myeloid leukemia: 2024 update on novel therapeutic strategies].
Minami Y; Yoshimaru R
Rinsho Ketsueki; 2024; 65(9):976-981. PubMed ID: 39358298
[TBL] [Abstract] [Full Text] [Related]
18. [Management of children and adolescents receiving CAR-T cell therapy for acute lymphoblastic leukemia].
Imai C
Rinsho Ketsueki; 2024; 65(9):1164-1173. PubMed ID: 39358274
[TBL] [Abstract] [Full Text] [Related]
19. PBA2, a novel inhibitor of the β-catenin/CBP pathway, eradicates chronic myeloid leukemia including bcr-ABL T315I mutation.
Yang K; Fu K; Zhang H; Wang X; To KKW; Yang C; Wang F; Chen ZS; Fu L
Mol Cancer; 2024 Sep; 23(1):209. PubMed ID: 39342174
[TBL] [Abstract] [Full Text] [Related]
20. Hsa_circ_0006010 and hsa_circ_0002903 in peripheral blood serve as novel diagnostic, surveillance and prognostic biomarkers for disease progression in chronic myeloid leukemia.
Zhao J; Wang G; Yan G; Zheng M; Li H; Bai Y; Zheng X; Chen Z
BMC Cancer; 2024 Sep; 24(1):1172. PubMed ID: 39304860
[TBL] [Abstract] [Full Text] [Related]
[Next]